Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
51.97 USD | +0.35% | +3.14% | +14.93% |
Strengths
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analyst opinion has improved significantly over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+14.93% | 9.94B | B+ | ||
+16.14% | 82.2B | B- | ||
+9.97% | 52.22B | B+ | ||
+9.84% | 42.44B | B+ | ||
+8.73% | 40.27B | B+ | ||
+20.54% | 38.35B | B | ||
+3.11% | 30.18B | B | ||
-7.82% | 27.48B | B- | ||
-17.13% | 25.31B | A- | ||
+7.65% | 21.95B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- UNM Stock
- Ratings Unum Group